These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4390899)

  • 1. Heat labile opsonins to pneumococcus. I. Participation of complement.
    Smith MR; Wood WB
    J Exp Med; 1969 Dec; 130(6):1209-27. PubMed ID: 4390899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins.
    Smith MR; Shin HS; Wood WB
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1151-6. PubMed ID: 4390986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.
    Shin HS; Smith MR; Wood WB
    J Exp Med; 1969 Dec; 130(6):1229-41. PubMed ID: 4390900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat labile opsonin system to pneumococcus.
    Shin HS; Smith MR; Winkelstein J; Nicholson A
    Birth Defects Orig Artic Ser; 1975; 11(1):563-6. PubMed ID: 238689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.
    Winkelstein JA; Shin HS; Wood WB
    J Immunol; 1972 Jun; 108(6):1681-9. PubMed ID: 4402312
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of opsonins in recovery from experimental pneumococcal pneumonia.
    Guckian JC; Christensen GD; Fine DP
    J Infect Dis; 1980 Aug; 142(2):175-90. PubMed ID: 6997403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytes.
    Guckian JC; Christensen GD; Schweinle JE; Fine DP
    J Immunol; 1981 Oct; 127(4):1659-65. PubMed ID: 7276577
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of serum opsonins on the phagocytosis of Staphylococcus aureus and zymosan particles, measured by flow cytometry.
    Bassøe CF; Bjerknes R
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):51-8. PubMed ID: 6711308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.
    HIRSCH JG; STRAUSS B
    J Immunol; 1964 Jan; 92():145-54. PubMed ID: 14139537
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for quantitative variability of bacterial opsonic requirements.
    Guckian JC; Christensen WD; Fine DP
    Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae.
    Coonrod JD; Yoneda K
    Rev Infect Dis; 1981; 3(2):310-22. PubMed ID: 7256089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonin.
    Stossel TP
    J Cell Biol; 1973 Aug; 58(2):346-56. PubMed ID: 4738105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
    Root RK; Ellman L; Frank MM
    J Immunol; 1972 Sep; 109(3):477-86. PubMed ID: 4403402
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonizing factors in human serum. II. The opsonin and inhibitor of phagocytosis of Staphylococcus aureus.
    Slopek S; Grzybek-Hryncewicz K; Ladosz J; Kubis-Parusel K
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):18-25. PubMed ID: 6057642
    [No Abstract]   [Full Text] [Related]  

  • 17. Opsonic activity in human serum deficient in C2.
    Johnson FR; Agnello V; Williams RC
    J Immunol; 1972 Jul; 109(1):141-5. PubMed ID: 4402482
    [No Abstract]   [Full Text] [Related]  

  • 18. Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells.
    Moghimi SM; Patel HM
    Biochim Biophys Acta; 1992 Jun; 1135(3):269-74. PubMed ID: 1623013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.
    Stossel TP; Alper CA; Rosen FS
    J Exp Med; 1973 Mar; 137(3):690-705. PubMed ID: 4631990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonizing factors in human serum. I. Factors inhibiting and stimulating phagocytosis of Shigella sonnei (phase II).
    Slopek S; Ladosz J; Grzybek-Hryncewicz K; Kubis-Parusel K
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):10-7. PubMed ID: 4965190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.